Search Results for Most Frequently Published Journals (Superfund Research Program)

Superfund Research Program

Search Results

Cancer Epidemiology, Biomarkers & Prevention : A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology (69 articles)

2021

• Whitehead TP, Wiemels JL, Zhou M, Kang AY, McCoy LS, Wang R, Fitch B, Petrick L, Yano Y, Imani P, Rappaport SM, Dahl GV, Kogan SC, Ma X, Metayer C. 2021. Cytokine levels at birth in children who developed acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 30(8):1526-1535. doi:10.1158/1055-9965.EPI-20-1704 PMID:34078642 PMCID:PMC8338848
• Xu K, Li S, Whitehead TP, Pandey P, Kang AY, Morimoto L, Kogan SC, Metayer C, Wiemels JL, de Smith AJ. 2021. Epigenetic biomarkers of prenatal tobacco smoke exposure are associated with gene deletions in childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 30:1517-1525. doi:10.1158/1055-9965.EPI-21-0009 PMID:34020997 PMCID:PMC8338876

2020

• Smith MT, Guyton KZ, Kleinstreuer N, Borrell A, Cardenas A, Chiu WA, Felsher DW, Gibbons CF, Goodson III WH, Houck K, Kane AB, La Merrill MA, Lebrec H, Lowe L, McHale CM, Minocherhomji S, Rieswijk L, Sandy MS, Sone H, Wang A, Zhang L, Zeise L, Fielden MR. 2020. The Key Characteristics of Carcinogens: Relationship to the Hallmarks of Cancer, Relevant Biomarkers, and Assays to Measure Them. Cancer Epidemiol Biomarkers Prev 29(10):doi:10.1158/1055-9965.EPI-19-1346 PMID:32152214 PMCID:PMC7483401

2019

• Andrew AS, Karagas MR, Schroeck FR, Marsit CJ, Schned AR, Pettus JR, Armstrong DA, Seigne JD. 2019. MicroRNA Dysregulation and Non-Muscle-Invasive Bladder Cancer Prognosis. Cancer Epidemiol Biomarkers Prev 28:728-788. doi:10.1158/1055-9965.EPI-18-0884 PMID:30700445 PMCID:PMC6473178
• Ugai T, Ito H, Oze I, Saito E, Rahman S, Boffetta P, Gupta PC, Sawada N, Tamakoshi A, Shu X, Koh W, Gao Y, Sadakane A, Tsuji I, Park SK, Nagata C, You S, Pednekar MS, Tsugane S, Cai H, Yuan J, Xiang Y, Ozasa K, Tomata Y, Kanemura S, Sugawara Y, Wada K, Chen C, Yoo K, Chia K, Ahsan H, Zheng W, Inoue M, Kang D, Potter JD, Matsuo K. 2019. Association of BMI, Smoking, and Alcohol with Multiple Myeloma Mortality in Asians: A Pooled Analysis of More than 800,000 Participants in the Asia Cohort Consortium. Cancer Epidemiol Biomarkers Prev 28:1861-1867. doi:10.1158/1055-9965.Epi-19-0389 PMID:31399476
• Vogtmann E, Chen J, Kibriya MG, Amir A, Shi J, Chen Y, Islam M, Eunes M, Ahmed A, Naher J, Rahman A, Barmon B, Knight R, Chia N, Ahsan H, Abnet CC, Sinha R. 2019. Comparison of oral collection methods for studies of microbiota. Cancer Epidemiol Biomarkers Prev 28:137-143. doi:10.1158/1055-9965.EPI-18-0312 PMID:30262598 PMCID:PMC6324947

2018

• Rothman N, Zhang L, Smith MT, Vermeulen R, Lan Q. 2018. Formaldehyde, hematotoxicity, and chromosomal changes-response. Cancer Epidemiol Biomarkers Prev 27:120-121. doi:10.1158/1055-9965.epi-17-0804 PMID:29311167

2017

• Howe CG, Liu X, Hall MN, Ilievski V, Caudill MA, Malysheva O, Lomax-Luu A, Parvez F, Siddique A, Shahriar H, Uddin MN, Islam T, Graziano JH, Costa M, Gamble MV. 2017. Sex-specific associations between one-carbon metabolism indices and posttranslational histone modifications in arsenic-exposed Bangladeshi adults. Cancer Epidemiol Biomarkers Prev 26(2):261-269. doi:10.1158/1055-9965.EPI-16-0202 PMID:27765800 PMCID:PMC5296278
• Patel CJ, Kerr J, Thomas DC, Mukherjee B, Ritz B, Chatterjee N, Jankowska M, Madan JC, Karagas MR, McAllister KA, Mechanic LM, Fallin MD, Ladd-Acosta C, Blair IA, Teitelbaum SL, Amos CI. 2017. Opportunities and challenges for environmental exposure assessment in population-based studies. Cancer Epidemiol Biomarkers Prev 26:1370-1380. doi:10.1158/1055-9965.epi-17-0459 PMID:28710076 PMCID:PMC5581729

2016

• Hsu LI, Briggs F, Shao XR, Metayer C, Wiemels JL, Chokkalingam AP, Barcellos L. 2016. Pathway analysis of genome-wide association study in childhood leukemia among Hispanics. Cancer Epidemiol Biomarkers Prev 25(5):815-822. doi:10.1158/1055-9965.EPI-15-0528 PMID:26941364 PMCID:PMC4873450
• Jansen RJ, Argos M, Tong L, Li J, Rakibuz-Zaman M, Islam MT, Slakovich V, Ahmed A, Navas-Acien A, Parvez F, Chen Y, Gamble MV, Graziano JH, Pierce BL, Ahsan H. 2016. Determinants and consequences of arsenic metabolism efficiency among 4,794 individuals: demographics, lifestyle, genetics, and toxicity. Cancer Epidemiol Biomarkers Prev 25(2):381-390. doi:10.1158/1055-9965.EPI-15-0718 PMID:26677206 PMCID:PMC4767610
• Perttula K, Edmands WM, Grigoryan H, Cai X, Iavarone A, Gunter MJ, Naccarati A, Polidoro S, Hubbard AE, Vineis P, Rappaport SM. 2016. Evaluating ultra-long-chain fatty acids as biomarkers of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 25(8):1216-1223. doi:10.1158/1055-9965.EPI-16-0204 PMID:27257090

2015

• Niedzwiecki M, Liu X, Hall MN, Thomas T, Slavkovich VN, Ilievski V, Levy D, Alam S, Siddique A, Parvez F, Graziano JH, Gamble MV. 2015. Sex-specific associations of arsenic exposure with global DNA methylation and hydroxymethylation in leukocytes: results from two studies in Bangladesh. Cancer Epidemiol Biomarkers Prev 24(11):1748-1757. doi:10.1158/1055-9965.EPI-15-0432 PMID:26364164 PMCID:PMC4633312

2014

• Daniels SI, Sille FC, Goldbaum A, Yee B, Key EF, Zhang L, Smith MT, Thomas R. 2014. Improving power to detect changes in blood miRNA expression by accounting for sources of variability in experimental designs. Cancer Epidemiol Biomarkers Prev 23(12):2658-2666. doi:10.1158/1055-9965.EPI-14-0623 PMID:25472674 PMCID:PMC4256675
• Steinmaus CM, Ferreccio Readi C, Acevedo J, Yuan Y, Liaw J, Duran V, Cuevas S, Garcia J, Meza R, Valdes R, Valdes G, Benitez H, VanderLinde V, Villagra V, Cantor KP, Moore LE, Perez S, Steinmaus S, Smith AH. 2014. Increased lung and bladder cancer incidence in adults after in utero and early-life arsenic exposure. Cancer Epidemiol Biomarkers Prev 23(8):1529-1538. doi:10.1158/1055-9965.EPI-14-0059 PMID:24859871 PMCID:PMC4344186

2013

• Arita A, Munoz A, Chervona Y, Niu J, Qu Q, Zhao N, Ruan Y, Kiok K, Kluz T, Sun H, Clancy HA, Shamy MY, Costa M. 2013. Gene expression profiles in peripheral blood mononuclear cells of Chinese nickel refinery workers with high exposures to nickel and control subjects. Cancer Epidemiol Biomarkers Prev 22(2):261-269. doi:10.1158/1055-9965.epi-12-1011 PMID:23195993 PMCID:PMC3565097
• Harper KN, Peters BA, Gamble MV. 2013. Batch effects and pathway analysis: Two potential perils in cancer studies involving DNA methylation array analysis. Cancer Epidemiol Biomarkers Prev 22(6):1052-1060. doi:10.1158/1055-9965.epi-13-0114 PMID:23629520 PMCID:PMC3687782
• Metayer C, Zhang L, Wiemels JL, Bartley K, Schiffman J, Ma X, Aldrich MC, Chang JS, Selvin S, Fu CH, Ducore J, Smith MT, Buffler PA. 2013. Tobacco smoke exposure and the risk of childhood acute lymphoblastic and Myeloid Leukemias by cytogenetic subtype. Cancer Epidemiol Biomarkers Prev 22(9):1600. doi:10.1158/1055-9965.epi-13-0350 PMID:23853208 PMCID:PMC3769478
• Steinmaus CM, Ferreccio Readi C, Romo JA, Yuan Y, Cortes S, Marshall G, Moore LE, Balmes JR, Liaw J, Golden T, Smith AH. 2013. Drinking water arsenic in Northern Chile: high cancer risks 40 years after exposure cessation. Cancer Epidemiol Biomarkers Prev 22:623-630. doi:10.1158/1055-9965.epi-12-1190 PMID:23355602 PMCID:PMC3848421

2012

• Chervona Y, Hall MN, Arita A, Wu F, Sun H, Tseng H, Ali E, Uddin MN, Liu X, Zoroddu MA, Gamble MV, Costa M. 2012. Association between arsenic exposure and global posttranslational histone modifications among adults in Bangladesh. Cancer Epidemiol Biomarkers Prev 21:2252-2260. doi:10.1158/1055-9965.epi-12-0833 PMID:23064002 PMCID:PMC3518638

2010

• Zhang L, Tang X, Rothman N, Vermeulen R, Ji Z, Shen M, Qiu C, Guo W, Liu S, Reiss B, Freeman LB, Ge Y, Hubbard AE, Hua M, Blair AE, Galvan N, Ruan X, Alter BP, Xin KX, Li S, Moore LE, Kim S, Xie Y, Hayes RB, Azuma M, Hauptmann M, Xiong J, Stewart P, Li L, Rappaport SM, Huang H, Fraumeni JF, Smith MT, Lan Q. 2010. Occupational exposure to formaldehyde, hematotoxicity, and leukemia-specific chromosome changes in cultured myeloid progenitor cells. Cancer Epidemiol Biomarkers Prev 19(1):80-88. doi:10.1158/1055-9965.EPI-09-0762 PMID:20056626 PMCID:PMC2974570

2009

• Chang JS, Buffler PA, Metayer C, Chokkalingam AP, Patoka J, Kronish D, Wiemels JL. 2009. Maternal immunoglobulin E and childhood leukemia. Cancer Epidemiol Biomarkers Prev 18(8):2221-2227. doi:10.1158/1055-9965.EPI-09-0212 PMID:19622720

2008

• Andrew AS, Karagas MR, Nelson HH, Guarrera S, Polidoro S, Gamberini S, Sacerdote C, Moore JH, Kelsey KT, Demidenko E, Vineis P, Matullo G. 2008. DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy. Cancer Epidemiol Biomarkers Prev 65(2):105-118. doi:10.1159/000108942 PMID:17898541 PMCID:PMC2857629
• Chang JS, Yeh R, Wiencke JK, Wiemels JL, Smirnov I, Pico AR, Tihan T, Patoka J, Miike R, Sison JD, Rice T, Wrensch MR. 2008. Pathway analysis of single-nucleotide polymorphisms potentially associated with glioblastoma multiforme susceptibility using random forests. Cancer Epidemiol Biomarkers Prev 17(6):1368-1373. doi:10.1158/1055-9965.EPI-07-2830 PMID:18559551
• Liaw J, Marshall G, Yuan Y, Ferreccio Readi C, Steinmaus CM, Smith AH. 2008. Increased childhood liver cancer mortality and arsenic in drinking water in northern Chile. Cancer Epidemiol Biomarkers Prev 17(8):1982-1987. doi:10.1158/1055-9965.EPI-07-2816 PMID:18708388 PMCID:PMC2694756

2007

• Ahsan H, Chen Y. 2007. Arsenic metabolism, genetic susceptibility and risk of pre-malignant skin lesions. Cancer Epidemiol Biomarkers Prev 16(6):1270-1278.
• Chen Y, Hall M, Graziano JH, Slavkovich VN, van Geen AF, Parvez F, Ahsan H. 2007. A prospective study of blood selenium levels and the risk of arsenic-related premalignant skin lesions. Cancer Epidemiol Biomarkers Prev 16(2):207-213. PMID:17301251
• Hsiung DT, Marsit CJ, Houseman EA, Eddy K, Furniss CS, McClean MD, Kelsey KT. 2007. Global DNA methylation level in whole blood as a biomarker in head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 16(1):108-14. PMID:17220338
• Kupper LL, Swenberg JA, Waiters JL, Satia JA, Schroeder JC. 2007. Associations of antioxidant nutrients and oxidative DNA damage in healthy African-American and White adults. Cancer Epidemiol Biomarkers Prev 16(7):1428-1436. doi:10.1158/1055-9965.EPI-06-1030 PMID:17627008
• Smith MT, Hartge P. 2007. Environmental and behavioral factors and the risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16(3):367-8. PMID:17344463
• Smith MT, Jones RM, Smith AH. 2007. Benzene exposure and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 16(3):385-391. doi:10.1158/1055-9965.EPI-06-1057 PMID:17337645
• Urayama KY, Wiencke JK, Buffler PA, Selvin S, Wiemels JL. 2007. MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 16(6):1172-1177. doi:10.1158/1055-9965.EPI-07-0007 PMID:17548681

2006

• Aldrich MC, Zhang L, Wiemels JL, Ma X, Loh ML, Metayer C, Selvin S, Feusner J, Smith MT, Buffler PA. 2006. Cytogenetics of hispanic and white children with acute lymphoblastic leukemia in california. Cancer Epidemiol Biomarkers Prev 15(3):578-581. PMID:16537719
• Argos M, Kibriya MG, Parvez F, Jasmine F, Rakibuz-Zaman M, Ahsan H. 2006. Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population. Cancer Epidemiol Biomarkers Prev 15(7):1367-1375. doi:10.1158/1055-9965.EPI-06-0106 PMID:16835338
• Kim S, Vermeulen R, Waidyanatha S, Johnson BA, Lan Q, Smith MT, Zhang L, Li G, Shen M, Yin S, Rothman N, Rappaport SM. 2006. Modeling human metabolism of benzene following occupational and environmental exposures. Cancer Epidemiol Biomarkers Prev 15(11):2246-52. PMID:17119053
• Paynter RA, Skibola DR, Skibola CF, Buffler PA, Wiemels JL, Smith MT. 2006. Accuracy of multiplexed Illumina platform-based single-nucleotide polymorphism genotyping compared between genomic and whole genome amplified DNA collected from multiple sources. Cancer Epidemiol Biomarkers Prev 15(12):2533-2536. doi:10.1158/1055-9965.EPI-06-0219 PMID:17164381
• Peters U, Chatterjee N, Church TR, Mayo C, Sturup S, Foster C, Schatzkin A, Hayes RB. 2006. High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Cancer Epidemiol Biomarkers Prev (15)2:315-320. PMID:16492922

2005

• Steinmaus CM, Yuan Y, Kalman DA, Atallah R, Smith AH. 2005. Intraindividual variability in arsenic methylation in a US population. Cancer Epidemiol Biomarkers Prev 14(4):919-924. doi:10.1158/1055-9965.EPI-04-0277 PMID:15824164
• Wiencke JK, Aldape K, McMillan A, Wiemels JL, Moghadassi M, Miike R, Kelsey KT, Patoka J, Long J, Wrensch MR. 2005. Molecular features of adult glioma associated with patient race/ethnicity, age, and a polymorphism in O6-methylguanine-DNA-methyltransferase. Cancer Epidemiol Biomarkers Prev 14(7):1774-1783. doi:10.1158/1055-9965.EPI-05-0089 PMID:16030116

2004

• Duramad P, McMahon CW, Hubbard AE, Eskenazi B, Holland NT. 2004. Flow cytometric detection of intracellular Th1/Th2 cytokines using whole blood: Validation of immunologic biomarker for use in epidemiologic studies. Cancer Epidemiol Biomarkers Prev 13(9):1452-1458. PMID:15342445
• Kelsey KT, Park S, Nelson HH, Karagas MR. 2004. A population-based case-control study of the XRCC1 Arg399Gln polymorphism and susceptibility to bladder cancer. Cancer Epidemiol Biomarkers Prev 13(8):1337-1341. PMID:15298955
• Selvin S. 2004. Cytochrome P450 1A1 polymorphism and childhood leukemia: An analysis of matched pairs case-control genotype data. Cancer Epidemiol Biomarkers Prev 13(8):1371-1374. PMID:15298960
• Waidyanatha S, Zheng Y, Serdar B, Rappaport SM. 2004. Albumin adducts of naphthalene metabolites as biomarkers of exposure to polycyclic aromatic hydrocarbons. Cancer Epidemiol Biomarkers Prev 13(1):117-124. PMID:14744742

2003

• Barbin A, Ohgaki H, Nakamura J, Kurrer M, Kleihues P, Swenberg JA. 2003. Endogenous deoxyribonucleic acid (DNA) damage in human tissues: A comparison of ethenobases with aldehydic DNA lesions. Cancer Epidemiol Biomarkers Prev 12(11):1241-1247. PMID:14652288
• Chen J, Hunter DJ, Stampfer MJ, Kyte C, Chan W, Wetmur JG, Selhub J, Ma J. 2003. Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer. Cancer Epidemiol Biomarkers Prev 12(10):958-962. PMID:14578129

2002

• Chen J, Gerner S, Higuchi R, Berkowitz GS, Godbold JH, Wetmur JG. 2002. Kinetic PCR on pooled DNA: a high efficiency alternative in genetic epidemiologic studies. Cancer Epidemiol Biomarkers Prev 11:131-136.
• Chen J, Ma J, Stampfer MJ, Hines LM, Selhub J, Hunter DJ. 2002. Alcohol dehydrogenase 3 genotype is not predictive for risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 10:1303-1304. PMID:11751450
• Chen Y, Amarasiriwardena CJ, Hsueh Y, Christiani DC. 2002. Stability of arsenic species and insoluble arsenic in human urine. Cancer Epidemiol Biomarkers Prev 11:1427-1433. PMID:12433722

2001

• Caggana M, Kilgallen J, Conroy JM, Wiencke JK, Kelsey KT, Miike R, Chen P, Wrensch MR. 2001. Associations between ERCC2 polymorphisms and gliomas. Cancer Epidemiol Biomarkers Prev 10:355-360. PMID:11319176
• Duell EJ, Millikan RC, Pittman G, Winkel S, Lunn RM, Tse CJ, Eaton A, Mohrenweiser HW, Newman B, Bell DA. 2001. Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev 10:217-222. PMID:11303590
• Kim HS, Newcomb PA, Ulrich CM, Keener CL, Farin FM, Bostick RM, Potter JD. 2001. Vitamin D receptor polymorphisms and the risk of colorectal adenomas: evidence of interaction with dietary vitamin D and calcium. Cancer Epidemiol Biomarkers Prev 10(8):869-874. PMID:11489753
• Mooney LA, Perera F, Van Bennekum AM, Blaner WS, Karkoszka J, Covey L, Hsu YZ, Cooper TB, Frenkel K. 2001. Gender differences in autoantibodies to oxidative DNA base damage in cigarette smokers. Cancer Epidemiol Biomarkers Prev 10:641-648. PMID:11401914
• Peters ES, Kelsey KT, Wiencke JK, Park S, Chen P, Miike R, Wrensch MR. 2001. NAT2 and NQO1 polymorphisms are not associated with adult glioma. Cancer Epidemiol Biomarkers Prev 10(2):151-152.
• Yeowell-O'Connell K, Rothman N, Waidyanatha S, Smith MT, Hayes RB, Li G, Bechtold WE, Dosemeci M, Zhang L, Yin S, Rappaport SM. 2001. Protein adducts of 1,4-benzoquinone and benzene oxide among smokers and nonsmokers exposed to benzene in China. Cancer Epidemiol Biomarkers Prev 10:831-838. PMID:11489749
• Zheng S, Ma X, Buffler PA, Smith MT, Wiencke JK. 2001. Whole genome amplification increases the efficiency and validity of buccal cell genotyping in pediatric populations. Cancer Epidemiol Biomarkers Prev 10:697-700. PMID:11401921

2000

• Chen P, Wiencke JK, Aldape K, Kesler-Diaz A, Miike R, Kelsey KT, Lee M, Liu J, Wrensch MR. 2000. Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev 9(8):843-847. PMID:10952103
• Hoppin JA, Tolbert PE, Holly EA, Brock JW, Korrick SA, Altshul LM, Zhang RH, Burse VW, Needham LL, Bracci PM. 2000. Pancreatic cancer and serum organochlorine levels. Cancer Epidemiol Biomarkers Prev 9(2):199-205. PMID:10698482
• Ulrich CM, Bigler J, Velicer CM, Greene EA, Farin FM, Potter JD. 2000. Searching expressed sequence tag (EST) databases: discovery and confirmation of a common polymorphism in the thymidylate synthase gene. Cancer Epidemiol Biomarkers Prev 9(12):1381-1385. PMID:11142426
• Wolff MS, Zeleniuch-Jacquotte A, Dubin N, Toniolo P. 2000. Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev 9:271-277. PMID:10750665

1999

• Wiencke JK, Zheng S, Lafuente A, Lafuente MJ, Grudzen C, Wrensch MR, Miike R, Ballesta A, Trias M. 1999. Aberrant methylation of p16(INK4a) in anatomic and gender specific subtypes of sporadic colorectal cancer. Cancer Epidemiol Biomarkers Prev 8(6):501-506. PMID:10385139
• Wolff MS, Anderson HA. 1999. Body mass and serum levels of organochlorines. Cancer Epidemiol Biomarkers Prev 8:

1998

• Weston A, Pan C, Bleiweiss IJ, Ksieski HB, Roy N, Maloney N, Wolff MS. 1998. CYP17 genotype and breast cancer risk. Cancer Epidemiol Biomarkers Prev 7:941-944. PMID:9796640

1997

• Ishibe N, Wiencke JK, Zuo Z, McMillan A, Spitz MR, Kelsey KT. 1997. Susceptibility to lung cancer in light smokers associated with Cyp1A1 polymorphisms and lung cancer in Mexican- and African-Americans. Cancer Epidemiol Biomarkers Prev 6(12):1075-1080. PMID:9419406
• Moore LE, Smith AH, Hopenhayn-Rich C, Biggs ML, Kalman DA, Smith MT. 1997. Decrease in bladder cell micronucleus prevalance after intervention to lower the concentration of arsenic in drinking water. Cancer Epidemiol Biomarkers Prev 6(12):1051-1056. PMID:9419402
• Moore LE, Smith AH, Hopenhayn-Rich C, Biggs ML, Kalman DA, Smith MT. 1997. Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water. Cancer Epidemiol Biomarkers Prev 6(1):31-36. PMID:8993795
• Weston A, Pan C, Ksieski HB, Wallenstein S, Berkowitz GS, Tartter PI, Bleiweiss IJ, Brower ST, Senie RT, Wolff MS. 1997. P53 haplotype determination in breast cancer. Cancer Epidemiol Biomarkers Prev 6:105-112. PMID:9037561
• Wiencke JK, Spitz MR, McMillan A, Kelsey KT. 1997. Lung cancer in Mexican-Americans and African-Americans is associated with the wildtype genotype of the NAD(P)H:quinone oxidoreductase polymorphism. Cancer Epidemiol Biomarkers Prev 6(2):87-92. PMID:9037558

1996

• Karagas MR, Morris J, Weiss JE, Spate VL, Baskett CK, Greenberg ER. 1996. Toenail samples as an indicator of drinking water arsenic exposure. Cancer Epidemiol Biomarkers Prev 5(10):849-852. PMID:8896897

1995

• Wiencke JK, Pemble S, Ketterer B, Kelsey KT. 1995. Gene deletion in glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol Biomarkers Prev 4(3):253-259. PMID:7606200